CONMED Corp — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-12-09

Reporting Person: Berge Terence M (VP-Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-09	Common Stock	S	2870	$100.64	Disposed	3042	Direct
2020-12-09	Common Stock	S	2038	$101.43	Disposed	1004	Direct
2020-12-09	Common Stock	M	5400	$59.96	Acquired	6404	Direct
2020-12-09	Common Stock	S	4593	$100.387	Disposed	1811	Direct
2020-12-09	Common Stock	S	807	$101.47	Disposed	1004	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-09	Options To Purchase Common Stock	$59.96	M	5400	Disposed	2028-03-01	Common Stock (5400)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.04 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.06 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F5: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.